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Objectives: South Koreans receive the bacillus Calmette-Guerin (BCG) vaccina-
tion, which influence the result of the tuberculin skin test (TST); however, only a
few studies have described the usefulness of the TST and interferon-g release
assay (IGRA) for diagnosing latent TB infection (LTBI). Therefore, our aim was to
determine the usefulness of the TST and IGRA for diagnosing LTBI in a household
contacts investigation.
Methods: We reviewed the 329 household contacts who visited Chung-Ang Uni-
versity Hospital (Seoul, Korea) from May 1, 2011 to February 28, 2014. To eval-
uate the effectiveness of TST and IGRA for the diagnosis of LTBI, we examined
the concordance rate between the two tests, based on age. We also evaluated
the risk factors for LTBI.
Results: The concordance rate between the two tests in individuals 0e24 years,
25e54 years, and over 55 years were 82.6% (k Z 0.64, p < 0.01), 68.9%
(k Z 0.40, p < 0.01), and 68.4% (k Z 0.35, p < 0.01), respectively. The ratio of
positive TST to negative IGRA was higher in individuals 25e44 years old, whereas
the ratio of negative TST to positive IGRA was higher in individuals older than 55
years old. Based on the TST, the risk factor for LTBI was a cavity (p < 0.01). When
using IGRA, the risk factors were contact time (p Z 0.04) and age over 55 years
old (p Z 0.02).
Conclusion: The concordance rate between TST and IGRA was not good after the
age of 25 years. The IGRA test reflects the known risk factors more exactly.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Tuberculosis (TB) remains a major public health
problem in the world, especially in low- and middle-
income countries. According to the World Health Or-
ganization, in 2011, there were 8.7 million new incident
TB cases and 0.99 million TB deaths (just under 0.43
million human immunodeficiency virus-associated TB
deaths) [1]. Tuberculosis is also a major public problem
in South Korea because the incidence and mortality
remain high [2]. Therefore, it is important to reduce the
TB incidence by continuous tuberculosis supervising
work.
The first priority in a TB prevention and control
program is the identification and treatment of all people
with active TB; the second priority is contact investi-
gation to find people who are exposed to TB patients [3,
4] In South Korea since 1995, the diagnosis and treat-
ment of latent TB infection (LTBI) in high-risk patients
has been added in TB supervising work. After 2011,
tuberculosis management guidelines have recommended
diagnosing and treating contact patients and active TB
patients. The tuberculin skin test (TST) and interferon-g
release assay (IGRA) are tests used in diagnosing LTBI.
Because the TST is affected by the bacillus Calmette-
Guerin (BCG) vaccination, the TST has low specificity
in the BCG vaccination population. The IGRA, which
measures in vitro interferon-g production by T cells
sensitized with the Mycobacterium tuberculosis antigens
ESAT-6 and CFP-10, was created in 1995 and was put
into practical use in 2000 [5,6] The IGRA offers better
specificity (98e100%) and good sensitivity (79e97%);
this test is unaffected by the BCG vaccination [7].
Therefore, IGRA is recommended for the BCG vacci-
nation population [8e10]. South Koreans receive BCG
vaccination in infancy. Therefore, the effectiveness of
TST, despite its simplicity, is being questioned in South
Korea. However, few studies have compared the use-
fulness of TST and IGRA for TB diagnosis in South
Korea. In this study, we aimed to compare the positive
rate of TST and IGRA in a contact investigation and to
determine the risk factors for LTBI.2. Materials and methods
2.1. Study design and participants
We performed a retrospective study at the Chung-
Ang University Hospital (Seoul, Korea) between May 1,
2011 and February 28, 2014. The study participants
included all patients with active TB and a household
contact population during these periods. We collected
demographic information, clinical data, acid-fast bacil-
lus (AFB) sputum smears, TB cultures, the presence of
cavitation on chest X-ray, TB-polymerase chain reac-
tion, and contact time. To compare the effectiveness of
TST and IGRA, we examined the positive rate andconcordance rate, based on age. We also analyzed the
risk factors of TST and IGRA.
2.2. Diagnosis of LTBI and active TB
Chest X-ray, IGRA, and TST were conducted on
contact patients. The TST was performed on the forearm
using a 2-tuberculin unit (TU) dose of purified protein
derivative RT23 (0.1 mL). Indurations were measured
after 48e72 hours. We defined a positive test result for
an induration diameter of 10 mm. The interferon-g
release assay was performed using the QFT-TB Gold-In-
Tube test (QFT-GIT; Cellestis Ltd, Carnegie, VIC,
Australia) in accordance with the manufacturer’s in-
structions. The results of IGRA were interpreted as
positive in 0.35 IU/mL [11] Active TB was diagnosed,
based on the presence ofM. tuberculosis in culture, AFB
in the microscopic examination of the clinical specimen,
or chest X-ray suggestive of TB with response to anti-
tuberculosis medications [12].
2.3. Statistical analysis
Statistical analysis was performed using SPSS
version 18 (SPSS Inc., Chicago, IL, USA). The data
were presented as the mean value with standard devia-
tion. The positive rate and risk factors between TST and
IGRA based on age was compared using the Chi-square
test. The concordance rate between the two tests was
evaluated using the k coefficient. A value of p < 0.05
was considered statistically significant.3. Results
From May 1, 2011 to February 28, 2014, 157 index
cases had 329 household contacts, and the contacts
performed contact investigation. Four (1.21%) contacts
were diagnosed as having active TB. One contact had a
positive culture and the remaining three contacts had
negative cultures. The median age of the close contacts
was 37.7  22.2 years. More than one-half (59.6%) of
the patients were female and 12 (3.8%) patients were
diabetic. The positive rate of TST and IGRA were
46.4% and 45.9%, respectively. Among the 157 index
patients, 43 (27.4%) patients had positive smears, 118
(75.2%) patients had positive cultures, and 22 (14.0%)
patients had a cavity on their chest X-ray (Table 1).
3.1. Positive rate of TST and IGRA, according
to age
The positive rate of TST of patients 25e34 years and
35e44 years was 46.3% and 63.8%, respectively. The
positive rate of IGRA in patients 25e34 years and
35e44 years was 21.4% and 47.8%, respectively. In the
p for trend value, the positive rate of TST did not tend to
increase with increasing age. However, IGRA results
tended to increase significantly with increasing age
(p < 0.01; Figure 1).
Table 1. Baseline characteristics of the contacts and the
index cases.
Number (%)
Contacts characteristics (n Z 329)
Sex, male 133 (40.4)
Age groups (y)
<15 73 (22.2)
15e24 25 (7.6)
25e34 45 (13.7)
35e44 48 (14.6)
45e54 45 (13.7)
55e64 58 (17.6)
65 35 (10.6)
Current smokers 23/284 (8.09)
Social alcoholics 34/261 (13.02)
Diabetes 12/310 (3.87)
Positive result of TST 145/312 (46.47)
Positive result of IGRA 108/235 (45.95)
Index characteristics (n Z 157)
Smear positive 43/157 (27.4)
Liquid culture positive 118/157 (75.2)
Solid culture positive 108/157 (68.8)
Cavity 22/157 (14.0)
IGRA Z interferon-g release assay; TST Z tuberculin skin test.
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according to age
Among 329 patients, 218 household contact patients
underwent the TST and IGRA together. Among this
population, the concordance rate was 70.2% (153/218).
The concordance rate between the two tests in patients
aged 0e24 years, 25e54 years, and over 55 years was
82.6%, 68.9%, and 68.4%, respectively. The k value
between the two tests was 0.638 (p < 0.01) in the 0e24
years age group, 0.404 (p< 0.01) in the 25e54 years age
group, and 0.350 (p < 0.01) in the >55 years age group
(Table 2). The ratio of the TSTþ/IGRA group was
higher (26.0%) in the 25e54 years age group than in the
other age groups. In patients aged >55 years, the ratio ofFigure 1. Positive rate of the tuberculin skin test and interferon-g
release assay; TST Z tuberculin skin test.the TSTþ/IGRA group was decreased substantially
(11.8%) and the ratio of the TST/IGRA þ group was
increased (19.7%).
3.3. Risk factors of TST and IGRA positivity in
household contacts
To see the diagnostic usefulness of TST and IGRA,
we assessed the relationship between the risk factors of
latent tuberculosis and these examinations. Among the
329 patients, the TST was performed in 312 contact
patients. When we used the TST as the diagnostic test
for LTBI in an unadjusted analysis, the risk factors for
LTBI were the presence of a lung cavity [odds ratio
(OR) Z 1.96, p Z 0.04]. In multivariate analysis, the
risk factor for TST positivity was the presence of a lung
cavity (ORZ 3.81, p < 0.01; Table 3). Among the 329
patients, IGRA was performed in 235 contact patients.
When we used the IGRA as the diagnostic test for LTBI
in an unadjusted analysis, the risk factors for LTBI were
age over 55 years (OR Z 3.00, p < 0.01), positive
smear results (OR Z 1.78, p Z 0.04), and contact time
of >10 hours per day (ORZ 2.13, pZ 0.02; Table 4).
In multivariate analysis, the risk factors for IGRA pos-
itivity were age over 55 years (OR Z 2.06, p Z 0.02)
and contact time of >10 hours (ORZ 2.06, pZ 0.04).
Smear positivity also showed a trend [OR Z 1.86;
confidence interval (CI), 0.98e3.53; p Z 0.06], but it
did not reach the statistical difference (Table 4).
On observing the positive rate of TST and IGRA by
contact time, the positive rate of IGRA tended to in-
crease significantly by contact time, (p Z 0.04). How-
ever, the TST did not show any tendency (Table 5).4. Discussion
A contact investigation is the most effective method
when supervising pulmonary tuberculosis in countries
with a low incidence of tuberculosis [13,14] In the past,release assay, according to age group. IGRA Z interferon-g
Table 2. The concordance rate of the tuberculin skin test and interferon-g release assay, according to age group (n Z 218).
Age TSTþ/IGRAþ TSTþ/IGRA TST/IGRAþ TST/IGRA Concordance rate (%) k p*
0e24 y 7/23 (30.4) 3/23 (13.0) 1/23 (4.3) 12/23 (52.1) 19/23 (82.6) 0.638 0.002
25e54 y 41/119 (34.4) 31/119 (26.0) 6/119 (5.0) 41/119 (34.4) 82/119 (68.9) 0.404 <0.001
55 y 33/76 (43.4) 9/76 (11.8) 15/76 (19.7) 19/76 (25.0) 52/76 (68.4) 0.350 0.002
Data are presented as n/N (%). IGRA Z interferon-g release assay; TSTZ tuberculin skin test. *A value of p < 0.05 indicates statistical significance.
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However, in many countries, IGRA is being introduced
as a standard method because it has high specificity and
good predictive value in the development of active TB.
[15,16] In the United States of America, IGRA can be
used as an alternative to TST (i.e., one-step strategy)
[17,18] In England and Norway, when the TST is pos-
itive, IGRA is recommended for diagnosing latent
tuberculosis (i.e., 2-step strategy) [19] In South Korea,
the TST is the basic method in diagnosing LTBI.
However, the TST/IGRA combined method or IGRA-
only method are allowed. However, it is important to
consider a false-positive response when using TST
because BCG vaccination can influence the results of
TST.
Our study showed a moderate concordance rate be-
tween TST and IGRA, which was 70.18% (153/218).
However, when we compared the concordance rate ac-
cording to age, the concordance was different. The k
value showed good concordance rate in individuals aged
0e24 years. However, the concordance rates decreased
with increasing age. In particular, the frequency of the
TSTþ/IGRA group is higher in the 25e54 years age
group than in the other groups. In addition, the TST
positive rate increased between 25 years and 54 years
but decreased after 55 years. However, the IGRA posi-
tivity rate significantly increased with age.Table 3. Risk factors for latent tuberculosis infection using tub
TST positive (n Z 145,
46.5%)
Contact characteristics
Male 63/145 (43.4)
Age (y) 41.2  20.3
Age over 55 y 42/145 (28.9)
Contact time (>10 h/d)a 58/109 (53.2)
Diabetesa 7/133 (5.3)
Index characteristics n Z 145 (46.5)
Smear positive 48/145 (33.1)
Liquid culture positive 112/145 (77.2)
Solid culture positive 104/145 (71.7)
Cavity 25/145 (17.2)
aThe contact time was surveyed in 109 patients and presence of diabetes was su
unless otherwise indicated. *A value of p < 0.05 indicates statistical significance.
ratio; TB Z tuberculosis; TST Z tuberculin skin test.The TST positive rate increases significantly with age
[20]. This is because old patients have more chances to
become infected during their lifetime in TB-endemic
areas. In addition, they are more vulnerable to TB
infection because of their decreased immunity. This
result is consistent with the IGRA positive rate in our
study. However, the TST positive rate did not show this
trend in this study. This can be explained by BCG
vaccination. Individuals who had BCG vaccination have
higher false-positive results with the TST [21,22].
However, some research suggests that the false-positive
effect decreases 5e10 years after BCG vaccination [23]
However, if individuals received boosting vaccination,
the effect can last up to 20 years [24]. In South Korea,
BCG revaccination at 12 years old was recommended
until 1997. After 1997, BCG vaccination has only been
recommended in infancy. We did not confirm the
boosting vaccination status in these populations,
although individuals over the age of 25 years probably
received BCG revaccination at the age of 12 years
because it was a national guideline. Therefore, the
25e54 years age group may have a higher false-positive
reaction in the TST.
The risk factors of tuberculosis infection have been
evaluated in several studies [25e27]. In our study, TST
positivity was associated with a cavity, and IGRA pos-
itivity was associated with an age over 55 years and aerculin skin test as the diagnostic method (n Z 312).
Unadjusted OR (95%
CI), p*
Adjusted OR (95% CI),
p*
0.83 (0.53e1.30), 0.42
1.11 (0.67e1.82), 0.69 1.43 (0.81e2.53), 0.22
0.99 (0.56e1.742), 0.97 1.05 (0.59e1.87), 0.88
1.72 (0.53e5.55), 0.35
1.38 (0.85e2.25), 0.19 1.43 (0.81e2.53), 0.22
1.03 (0.61e1.75), 0.90
1.24 (0.76e2.02), 0.37
1.96 (0.10e3.84), 0.04 3.81 (1.61e9.02), <0.01
rveyed in 133 patients only. Data are presented as n/N (%) or mean  SD,
CIZ confident interval; IGRAZ interferon-g release assays; ORZ odds
Table 4. Risk factors for latent tuberculosis infection using interferon-gamma release assay as the diagnostic method
(n Z 235).
IGRA positive
(n Z 108, 46.0%)
Unadjusted OR
(95% CI), p*
Adjusted OR
(95% CI), p*
Contact cases
Male 39/108 (36.1) 1.18 (0.69e2.01), 0.52
Age (y) 50.7  16.1
Age > 55 y 51/108 (47.2) 3.00 (1.72e5.24), <0.01 2.06 (1.10e3.84), 0.02
Contact time (>10 h/d)a 44/87 (50.6) 2.13 (1.10e4.12), 0.02 2.06 (1.05e4.05), 0.04
Diabetesa 5/97 (5.2) 1.03 (0.30e3.49), 0.95
Index cases n Z 108 (45.9)
Smear positive 40/108 (37.0) 1.78 (1.01e3.13), 0.04 1.86 (0.98e3.53), 0.06
Liquid culture positive 86/108 (79.6) 1.28 (0.69e2.39), 0.42
Solid culture positive 81/108 (75.0) 1.41 (0.79e2.51), 0.23
Cavity 13/108 (12.0) 0.77 (0.36e1.65), 0.51 1.11 (0.45e2.71), 1.11
aThe contact time was surveyed in 108 patients and the presence of diabetes was surveyed in 97 patients only. Data are presented as n/N (%) or mean  SD,
unless otherwise indicated. * A value of p< 0.05 indicates statistical significance. CIZ confident interval; IGRAZ interferon-g release assays; ORZ odds
ratio; TST Z tuberculin skin test.
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the AFB smear examination of patients with TB has
been associated with TB infection among contacts. Our
study also showed that the result of the sputum exami-
nation was associated with LTBI when we used IGRA
as the diagnostic method in an unadjusted analysis. We
failed to reach the statistical difference in the multi-
variate analysis, although the OR was similar in adjusted
analysis. Therefore, if the sample size increased, a sta-
tistical difference may be observed.
The length of exposure to index cases is also an
important factor for LTBI. We found it was associated
with LTBI when we used IGRA. The positive rate was
increased by the contact time when we used IGRA as the
diagnostic method for diagnosing LTBI. However, when
we used the TST, it was not a risk factor for LTBI. A
positive reaction to TST or IGRAdoes not represent recent
infection. South Korea is an intermediate TB burden
country. Therefore, some people have been infected pre-
viously. It could be more prominent in older populations.
There is no method to differentiate between a recent
infection and a previous infection. Therefore, our evalu-
ation of the risk factors for TB infection could have some
bias. However, our results showed that IGRA is more
consistent, compared to the results of previous studies.
Therefore, in South Korea, IGRA may be more valuable
for contact investigation of people over the age of 25 years.
Four persons among the 329 contacts were diagnosed
as having active TB during the contact investigation. ItTable 5. The positive rate of tuberculin skin test and interferon
0e5 h 5e10 h
IGRA positive 42/97 (43.3) 15/41 (36.6) 1
TST positive 51/113 (45.1) 25/45 (55.6) 2
Data are presented as n/N (%). * A value of p < 0.05 indicates statistical signiis difficult to decide that active TB originated from the
index cases, but the incidence (1215 per 100,000) is
higher than the incidence of active TB in South Korea
(which is 100 per 100,000). In addition, three patients
among four active TB patients had no symptoms. Early
diagnosis of active TB is an important tool to control
TB. Therefore, chest X-ray is an important tool in
contact investigations in TB-endemic areas.
Our study has several limitations. First, all contacts
were not screened by the two tests together because of
the study’s retrospective design. Therefore, this could
cause some selection bias. Second, because of the
retrospective study design, all information was not
gathered from the contacts. We also could not check the
patients’ BCG vaccination status. However, the BCG
vaccination program followed the national guideline.
Therefore, the possibility of no vaccination could be
low. Finally, the small sample size made it difficult to
obtain the statistical difference. Therefore, a large group
prospective study is needed.
In conclusion, the concordance rate between TST
and IGRA in patients over the age of 25 years is not
good (Table 5). The TSTþ/IGRA rate was high
among patients aged 25e54 years. In addition, the
positive result of IGRA was associated with contact
time, old age, and smear positivity. Therefore, the
possibility of false-positive reaction on TST must be
considered in people who received a boosting BCG
vaccination.-gamma release assay, according to contact time.
10e15 h 15e20 h 20e25 h p*
8/32 (56.3) 3/5 (60.0) 9/13 (69.2) 0.04
3/42 (54.8) 2/5 (40.0) 8/22 (36.4) 0.80
ficance. IGRAZ interferon-g release assay; TSTZ tuberculin skin test.
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